Synopsis McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health, Lupin said in a statement. Agencies NEW DELHI: Drug firm Lupin on Tuesday announced the appointment of Mark D McDade as an independent director effective January 28, 2021, for a period of five years. McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health, Lupin said in a statement. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced biotech companies, it added.